MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-13-2026
Exact Sciences Corporation Total Liabilities 2011-2026 | EXAS
Annual Total Liabilities Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.46 B | 3.53 B | 3.33 B | 3.18 B | 3.3 B | 2.1 B | 1.22 B | 843 M | 78.1 M | 41.7 M | 37.4 M | 22.6 M | 11.3 M | 13.5 M | 13.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.53 B | 11.3 M | 1.41 B |
Quarterly Total Liabilities Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.4 B | 3.33 B | 3.31 B | 3.53 B | 3.54 B | 3.48 B | 3.24 B | 3.33 B | 3.3 B | 3.3 B | 3.25 B | 3.18 B | 3.2 B | - | 3.23 B | 3.3 B | 3.2 B | 3.17 B | 3.09 B | 2.69 B | 2.69 B | 2.69 B | 2.69 B | 1.22 B | 1.22 B | 1.22 B | 1.22 B | 843 M | 843 M | 843 M | 843 M | 78.1 M | 78.1 M | 78.1 M | 78.1 M | 41.7 M | 41.7 M | 41.7 M | 41.7 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 11.3 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.54 B | 11.3 M | 1.68 B |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.32 B | $ 116.96 | 1.23 % | $ 35.6 B |  USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 1.72 | 2.99 % | $ 2.29 M | USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 25.0 | 2.21 % | $ 694 M | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
110 M | $ 21.37 | 0.66 % | $ 1.14 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 16.33 | 0.12 % | $ 494 M | USA |
 |
Illumina
ILMN
|
2.7 B | $ 128.0 | 0.09 % | $ 20.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 171.98 | 1.3 % | $ 8.52 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
2.11 B | $ 88.84 | -0.08 % | $ 11.1 B | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 84.31 | -0.03 % | $ 5.69 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 412.77 | 0.54 % | $ 11.9 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 27.63 | 0.58 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Senseonics Holdings
SENS
|
65.2 M | $ 7.05 | - | $ 294 M | USA |
 |
Neogen Corporation
NEOG
|
1.37 B | $ 9.6 | 0.58 % | $ 2.08 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.12 | -0.93 % | $ 4.87 M | USA |
 |
National Research Corporation
NRC
|
121 M | $ 17.33 | 0.55 % | $ 388 M | USA |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 101.21 | -0.94 % | $ 8.35 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 263.81 | 0.03 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
28.7 B | $ 473.8 | 0.9 % | $ 179 B | USA |
 |
Celcuity
CELC
|
366 M | $ 125.71 | 3.87 % | $ 5.88 B | USA |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.64 | -1.34 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
2.48 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
523 M | $ 8.41 | 1.45 % | $ 1.08 B | USA |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 61.16 | 0.36 % | $ 3.66 B | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 4.91 | 2.72 % | $ 455 M | USA |
 |
Natera
NTRA
|
689 M | $ 206.02 | 1.11 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 196.49 | 0.14 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
1.85 B | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
4.92 B | - | -0.91 % | $ 14.7 B | USA |
 |
Organovo Holdings
ONVO
|
4.16 M | - | -2.3 % | $ 19.4 M | USA |